Spruce Biosciences
$17.819876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$17.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.33 (-1.82%) As of 5:22 PM UTC today
Why Robinhood?
You can buy or sell SPRB and other stocks, options, and ETFs commission-free!
About SPRB
Spruce Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing novel therapies for rare diseases affecting the endocrine system. The company was founded in 2014 and is headquartered in Daly City, CA. The listed name for SPRB is Spruce Biosciences, Inc. Common Stock.
CEO
Richard A. King
Employees
—
Headquarters
Daly City, California
Founded
2014
Market Cap
466.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
29.03K
High Today
$18.40
Low Today
$17.31
Open Price
$18.17
Volume
13.50K
52 Week High
$35.60
52 Week Low
$15.12
SPRB Earnings
-$12.35
-$8.23
-$4.12
-$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, After Hours